May 9th 2024
Sofosbuvir/velpatasvir/voxilaprevir rescue therapy was safe and effective, and SVR did not significantly differ based on genotype, cirrhosis, or first-line therapy.
Improving the Care Cascade: Early Intervention for Perinatal HCV, with Megan Rose Curtis, MD
March 15th 2024Curtis discusses findings from her recent health economic study about the cost-effectiveness of treating perinatal HCV earlier, a growing concern amid rising rates of HCV in reproductive-aged adults.
Crisis Point: Stigma Hinders Adoption of Hepatitis C-Positive Donor Kidneys
March 14th 2024To acknowledge World Kidney Day, our latest episode of Crisis Point focuses on the stigma surrounding the use of HCV-positive donor kidneys amid the ongoing organ shortage crisis, with the perspective of a pair of experts and an HCV donor kidney recipient.